Bioceres Crop Solutions (BIOX) Cash & Current Investments (2016 - 2026)

Bioceres Crop Solutions has reported Cash & Current Investments for 11 years, with the latest figure at $13.9 million in Q1 2026.

• Quarterly Cash & Current Investments fell 59.56% year-over-year to $13.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.9 million (down 59.56% YoY) and the FY2025 annual result came in at $46.5 million, down 31.22% from the prior year.
• Cash & Current Investments retreated to $13.9 million in Q1 2026 per BIOX's latest filing, from $34.2 million in the prior quarter.
• Over five years, Cash & Current Investments peaked at $64.6 million in Q1 2024 and troughed at $13.9 million in Q1 2026.
• A 5-year average of $41.3 million and a median of $36.8 million in 2022 frame the typical range for Cash & Current Investments.
• The sharpest annual moves came in 2023 and 2026: Cash & Current Investments soared 91.81% in 2023, then plunged 59.56% in 2026.
• Over 5 years, Cash & Current Investments stood at $49.7 million in 2022, then tumbled by 37.3% to $31.1 million in 2023, then increased by 24.7% to $38.8 million in 2024, then slipped by 11.87% to $34.2 million in 2025, then sank by 59.37% to $13.9 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $13.9 million, $34.2 million, and $33.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.